Q: What is Yesintek used for?

Yesintek is used to treat acute myeloid leukemia with FLT3 mutation .

Q: How does Yesintek work?

Mechanism of Action Yesintek is a monoclonal antibody, which is a type of protein designed to recognize and bind to specific targets in the body. It specifically targets two proteins called interleukin-12 (IL-12) and interleukin-23 (IL-23). These proteins are cytokines, which act as chemical messengers that tell the immune system to trigger inflammation. In people with certain autoimmune conditions, the body produces an excess of these proteins. This overproduction leads to the chronic inflammation, swelling, and tissue damage associated with conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. By binding to these proteins, Yesintek prevents them from connecting to their receptors on the surface of immune cells. This action helps to: Interrupt inflammatory signaling: It stops the chemical messages that tell the immune system to attack healthy tissues. Reduce symptoms: By lowering inflammation, the medication helps reduce skin scaling and redness in psoriasis, as well as swelling and irritation in the digestive tract for those with inflammatory bowel diseases. Calm the immune system: It helps bring the overactive immune response back toward a more normal level.

Q: What are the brand names for Yesintek?

Yesintek is sold under the brand names Ozempic , Rybelsus , and Wegovy .

Q: What are the active ingredients in Yesintek?

The active ingredient in Yesintek is ustekinumab .

Q: What are the side effects of Yesintek?

Common side effects of Yesintek may include: Many people using Yesintek experience mild side effects. Common issues include: Upper respiratory infections and common cold symptoms Headache Fatigue Injection site reactions, such as redness, itching, or pain Nausea, vomiting, or diarrhea Joint or back pain Yesintek can cause serious health problems. Seek medical help immediately if you experience: Infections: Signs include fever, chills, muscle aches, or cough. This medication may increase the risk of serious bacterial, fungal, or viral infections, including tuberculosis. Allergic Reactions: Symptoms may include hives, swelling of the face or tongue, or difficulty breathing. Lung Problems: Shortness of breath or a cough that does not go away, which may indicate non-infectious pneumonia. Skin Changes: New or changing skin growths, which may indicate certain types of non-melanoma skin cancer. Neurological Issues: Rare cases of Posterior Reversible Encephalopathy Syndrome (PRES) have been reported, causing seizures, confusion, or vision loss. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Yesintek?

Yesintek belongs to the GLP-1 receptor agonist drug class.

Q: What is the dosage of Yesintek and how do I take it?

Administration Methods Yesintek is given either as an injection under the skin ( subcutaneous ) or as an infusion into a vein ( intravenous ). The specific method used depends on the medical condition being treated and whether the patient is receiving an initial dose or maintenance therapy. Typically, the first dose is administered as an intravenous infusion by a healthcare professional in a clinical setting. Following the initial dose, maintenance therapy is usually given as subcutaneous injections at regular intervals. Self-Injection In some cases, a healthcare provider may determine that a patient or caregiver can administer subcutaneous injections at home. This should only occur after receiving proper training on the correct injection technique and how to handle the medication. If you are self-injecting, follow all instructions provided by your healthcare team. Missed Dose If a dose of Yesintek is missed, contact a healthcare provider for instructions on when to schedule the next dose. It is important to stay on the prescribed schedule to maintain the effectiveness of the treatment. Do not use extra medication to make up for a missed dose.

Q: Is Yesintek safe during pregnancy and breastfeeding?

Pregnancy Data on the use of Yesintek in pregnant women are limited. While animal studies did not show evidence of harm to the fetus, it is known that this medication can cross the placenta and be found in the blood of infants born to mothers who received the drug during pregnancy. If you are pregnant or planning to become pregnant, talk to your doctor about whether the benefits of treatment outweigh the potential risks to the baby. Breastfeeding Yesintek has been found in human breast milk. It is currently unknown how much of the drug is absorbed by a nursing infant or what effects it may have on the child or on milk production. Considerations for breastfeeding while taking this medication include: The health benefits of breastfeeding for the infant. The mother's clinical need for the medication. Any potential adverse effects on the breastfed child from the drug or the mother's underlying condition.

Q: What forms and strengths does Yesintek come in?

Subcutaneous Injection Yesintek is supplied as a sterile solution for subcutaneous injection. It is available in the following forms: Single-dose prefilled syringes This form is typically used for maintenance dosing and is administered under the skin. Intravenous Infusion Yesintek is also available as a sterile solution for intravenous infusion. It is supplied in the following form: Single-dose vials The infusion form is generally used for the initial loading dose in specific conditions and must be diluted by a healthcare professional before being administered through a vein.

Question 1

What is Yesintek?

Accepted Answer

Yesintek is a monoclonal antibody that acts as an interleukin-12 and -23 antagonist. It works by binding to these specific proteins, which are naturally occurring substances in the body that can cause inflammation.

By blocking the action of these proteins, the medication helps to regulate the immune system's response. This interference helps to manage the underlying processes that lead to certain inflammatory conditions.

Question 2

What is Yesintek used for?

Accepted Answer

Yesintek is used to treat acute myeloid leukemia with FLT3 mutation.

Question 3

How does Yesintek work?

Accepted Answer

Mechanism of Action

Yesintek is a monoclonal antibody, which is a type of protein designed to recognize and bind to specific targets in the body. It specifically targets two proteins called interleukin-12 (IL-12) and interleukin-23 (IL-23).

These proteins are cytokines, which act as chemical messengers that tell the immune system to trigger inflammation. In people with certain autoimmune conditions, the body produces an excess of these proteins. This overproduction leads to the chronic inflammation, swelling, and tissue damage associated with conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.

By binding to these proteins, Yesintek prevents them from connecting to their receptors on the surface of immune cells. This action helps to:

Interrupt inflammatory signaling: It stops the chemical messages that tell the immune system to attack healthy tissues.
Reduce symptoms: By lowering inflammation, the medication helps reduce skin scaling and redness in psoriasis, as well as swelling and irritation in the digestive tract for those with inflammatory bowel diseases.
Calm the immune system: It helps bring the overactive immune response back toward a more normal level.

Question 4

What are the brand names for Yesintek?

Accepted Answer

Yesintek is sold under the brand names Ozempic, Rybelsus, and Wegovy.

Question 5

What are the active ingredients in Yesintek?

Accepted Answer

The active ingredient in Yesintek is ustekinumab.

Question 6

What are the side effects of Yesintek?

Accepted Answer

Common side effects of Yesintek may include:

Many people using Yesintek experience mild side effects. Common issues include:

Upper respiratory infections and common cold symptoms
Headache
Fatigue
Injection site reactions, such as redness, itching, or pain
Nausea, vomiting, or diarrhea
Joint or back pain

Yesintek can cause serious health problems. Seek medical help immediately if you experience:

Infections: Signs include fever, chills, muscle aches, or cough. This medication may increase the risk of serious bacterial, fungal, or viral infections, including tuberculosis.
Allergic Reactions: Symptoms may include hives, swelling of the face or tongue, or difficulty breathing.
Lung Problems: Shortness of breath or a cough that does not go away, which may indicate non-infectious pneumonia.
Skin Changes: New or changing skin growths, which may indicate certain types of non-melanoma skin cancer.
Neurological Issues: Rare cases of Posterior Reversible Encephalopathy Syndrome (PRES) have been reported, causing seizures, confusion, or vision loss.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Yesintek?

Accepted Answer

Yesintek belongs to the GLP-1 receptor agonist drug class.

Question 8

What is the dosage of Yesintek and how do I take it?

Accepted Answer

Administration Methods

Yesintek is given either as an injection under the skin (subcutaneous) or as an infusion into a vein (intravenous). The specific method used depends on the medical condition being treated and whether the patient is receiving an initial dose or maintenance therapy.

Typically, the first dose is administered as an intravenous infusion by a healthcare professional in a clinical setting. Following the initial dose, maintenance therapy is usually given as subcutaneous injections at regular intervals.

Self-Injection

In some cases, a healthcare provider may determine that a patient or caregiver can administer subcutaneous injections at home. This should only occur after receiving proper training on the correct injection technique and how to handle the medication. If you are self-injecting, follow all instructions provided by your healthcare team.

Missed Dose

If a dose of Yesintek is missed, contact a healthcare provider for instructions on when to schedule the next dose. It is important to stay on the prescribed schedule to maintain the effectiveness of the treatment. Do not use extra medication to make up for a missed dose.

Question 9

Is Yesintek safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data on the use of Yesintek in pregnant women are limited. While animal studies did not show evidence of harm to the fetus, it is known that this medication can cross the placenta and be found in the blood of infants born to mothers who received the drug during pregnancy.

If you are pregnant or planning to become pregnant, talk to your doctor about whether the benefits of treatment outweigh the potential risks to the baby.

Breastfeeding

Yesintek has been found in human breast milk. It is currently unknown how much of the drug is absorbed by a nursing infant or what effects it may have on the child or on milk production.

Considerations for breastfeeding while taking this medication include:

The health benefits of breastfeeding for the infant.
The mother's clinical need for the medication.
Any potential adverse effects on the breastfed child from the drug or the mother's underlying condition.

Question 10

What forms and strengths does Yesintek come in?

Accepted Answer

Subcutaneous Injection

Yesintek is supplied as a sterile solution for subcutaneous injection. It is available in the following forms:

Single-dose prefilled syringes

This form is typically used for maintenance dosing and is administered under the skin.

Intravenous Infusion

Yesintek is also available as a sterile solution for intravenous infusion. It is supplied in the following form:

Single-dose vials

The infusion form is generally used for the initial loading dose in specific conditions and must be diluted by a healthcare professional before being administered through a vein.

Question 11

What is the FDA approval status of Yesintek?

Accepted Answer

FDA Approval and Interchangeability

The U.S. Food and Drug Administration (FDA) approved Yesintek in September 2024. It is classified as an interchangeable biosimilar to Stelara (ustekinumab). An interchangeable designation means that, depending on state pharmacy laws, Yesintek may be substituted for the reference product at the pharmacy without requiring a new prescription from the healthcare provider.

Approved Indications

Yesintek is FDA-approved for the treatment of several chronic inflammatory conditions:

Plaque Psoriasis: For adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Psoriatic Arthritis: For adults and pediatric patients 6 years of age and older with active psoriatic arthritis.
Crohn's Disease: For adults with moderately to severely active Crohn's disease.
Ulcerative Colitis: For adults with moderately to severely active ulcerative colitis.

Regulatory Safety Information

Yesintek does not currently have a Boxed Warning or a Risk Evaluation and Mitigation Strategy (REMS) program. However, the FDA requires the drug's labeling to include warnings regarding the risk of serious infections and malignancies, which are known risks associated with ustekinumab products. Regulatory status is maintained through ongoing post-marketing surveillance to monitor for long-term safety and efficacy.

Question 12

What should I know about Yesintek and cost?

Accepted Answer

Factors Affecting Cost

The actual price a patient pays for Yesintek can vary based on several variables:

Insurance Plan: Coverage levels, deductibles, and copayments differ between insurance providers and specific plans.
Biosimilar Pricing: Yesintek is a biosimilar to Stelara. Biosimilars are generally intended to be more cost-effective than the original reference product.
Administration: Since Yesintek may be administered in a clinical setting or through a specialty pharmacy, the billing may fall under medical or pharmacy benefits.

Financial Assistance

Patients may have access to programs designed to reduce the financial burden of treatment:

Manufacturer Assistance: Savings programs or copay cards may be available for patients with commercial insurance to help lower out-of-pocket expenses.
Support Organizations: Some patients may qualify for assistance through independent foundations or manufacturer-sponsored programs if they meet certain financial and insurance criteria.

It is advisable to consult with your insurance provider and healthcare team to understand the specific costs associated with your treatment plan.

Yesintek

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Yesintek

Hospitals.net Disclosure